Skip to main content

The Effects of Adrenoceptor and Adrenergic Blocking Drugs on Plasma Lipoproteins

  • Conference paper
Drugs Affecting Lipid Metabolism

Part of the book series: Proceedings in Life Sciences ((LIFE SCIENCES))

  • 208 Accesses

Abstract

The catecholamines synthesized and secreted by the adrenal medulla regulate a wide spectrum of metabolic processes. Glugoneogenesis, glycogenosis and lipolysis, for example, are strongly influenced by catecholamines.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Day JL, Metcalfe J, Simpson CN (1982) Adrenergic mechanisms in control of plasma lipid concentrations. Br Med J 284:1145–1148

    Article  CAS  Google Scholar 

  • Lehtonen A (1984) The effect of acebutolol on plasma lipids, blood glucose and serum insulin levels. Acta Med Scand 216:57–60

    Article  PubMed  CAS  Google Scholar 

  • Lehtonen A, Marniemi J (1984) Effect of atenolol on plasma HDL-cholesterol subfractions. Atherosclerosis 51:335–338

    Article  PubMed  CAS  Google Scholar 

  • Lehtonen A, Viikari J (1979) Long-term effect of sotalol on plasma lipids. Clin Sci 57 (Suppl): 405–407

    Google Scholar 

  • Lehtonen A, Hietanen E, Marniemi J, Peltonen P, Niskanen J (1982) Effect of pinodolol on serum lipids and lipid metabolizing enzymes. Br J Clin Pharmacol 13 (Suppl 2):445–447

    Google Scholar 

  • Lehtonen A, Himanen P, Saraste M, Niittymäki K, Marniemi J (1986) Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins. Br J Clin Pharmacol 21:77–81

    Google Scholar 

  • Leren P, Helgeland A, Holme I, Foss OP, Hjermann I, Lund-Larsen PG (1980) Effect of propranolol and prazosin on blood lipids. The Oslo study. Lancet ii:4–6

    Article  Google Scholar 

  • Sacks FM, Dzau VJ (1986) Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action. Am J Med 80 (Suppl 2A):71–81

    Article  PubMed  CAS  Google Scholar 

  • Sihiff H, Weidmann P, Mordasini R, Riesen W, Bachmann C (1982) Reversal of diuretic-induced increases in serum low-density lipoprotein cholesterol by the beta-blocker pindolol. Metabolism 31:411–416

    Article  Google Scholar 

  • Välimäki M, Maass L, Harno K, Nikkilä EA (1986) Lipoprotein lipids and apoproteins during beta-blocker administration: comparison of penbutolol and atenolol. Eur J Clin Pharmacol 30:17–20

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Lehtonen, A. (1987). The Effects of Adrenoceptor and Adrenergic Blocking Drugs on Plasma Lipoproteins. In: Paoletti, R., Kritchevsky, D., Holmes, W.L. (eds) Drugs Affecting Lipid Metabolism. Proceedings in Life Sciences. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71702-4_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71702-4_40

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-71704-8

  • Online ISBN: 978-3-642-71702-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics